Specifically, we found that healthy MSCs exposed to MM cells underwent gains (HOXA9, ACVR2A, EBF2) and losses (HOXA2, HOXA3, HOXC5) of DNA methylation in the direction of those observed for MSCs from myeloma patients (Fig. 3F). This evidence concerns the gene EBF2 and plasma cell myeloma.